Breast

Most recent

New Strategies in the Treatment of HER2-Positive Breast Cancer

NE Oncology Issue - February 2014 Breast cancer Overexpression of the human epidermal growth factor receptor 2 (HER2) protein is detected in the tumours of approximately 20% of patients with breast cancer, conferring an aggressive phenotype...

Confirmatory overall survival analysis of CLEOPATRA: a randomized, doubleblind, placebo-controlled phase III study with pertuzumab, trastuzumab, and docetaxel in patients with HER2-positive first-line metastatic breast cancer

NE Oncology Issue - April 2013 Swain S, et al. SABCS 2012:P5-18-26 Background The CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) study randomized patients with human epidermal growth factor receptor 2 (HER2)- positive first-line metastatic breast cancer...

Twitter feed

Dr. Irwindeep Sandhu provides an analysis of the TOURMALINE-MM3 study with post-ASCT patients receiving #ixazomib m… https://t.co/ll9s4q7vCL
h J R
Dr. Brian Leber discusses long-term follow-up of patients with #myelofibrosis treated with #JAK inhibitors #EHA2019… https://t.co/G4FuspL3NK
h J R
Dr. Darrell White writes about the impact of age on efficacy and safety from the MAIA trial in transplant-ineligibl… https://t.co/00XDPvNCVo
h J R
Dr. Irwindeep Sandhu talks about the importance of studying real-world Canadian data in #multiplemyeloma #EHA2019… https://t.co/WHNsd75EPZ
h J R
Dr. Brian Leber discusses a re-analysis of the JAKARTA-2 study in patients with myeloproliferative neoplasm-associa… https://t.co/GyZFmwk7sq
h J R

Other

Twitter feed

Dr. Irwindeep Sandhu provides an analysis of the TOURMALINE-MM3 study with post-ASCT patients receiving #ixazomib m… https://t.co/ll9s4q7vCL
h J R
Dr. Brian Leber discusses long-term follow-up of patients with #myelofibrosis treated with #JAK inhibitors #EHA2019… https://t.co/G4FuspL3NK
h J R
Dr. Darrell White writes about the impact of age on efficacy and safety from the MAIA trial in transplant-ineligibl… https://t.co/00XDPvNCVo
h J R
Dr. Irwindeep Sandhu talks about the importance of studying real-world Canadian data in #multiplemyeloma #EHA2019… https://t.co/WHNsd75EPZ
h J R
Dr. Brian Leber discusses a re-analysis of the JAKARTA-2 study in patients with myeloproliferative neoplasm-associa… https://t.co/GyZFmwk7sq
h J R